Loading...
Indian Pharmaceutical Exporter · #13 for Esomeprazole · $3.1M export value · DGFT Verified
Sun Pharmaceutical Industries Ltd is the #13 Indian exporter of Esomeprazole with $3.1M in export value and 63 verified shipments. Sun Pharmaceutical Industries Ltd holds a 0.7% market share in Esomeprazole exports across 8 countries.
| 8.1% |
| SOUTH AFRICA | $3.5M | 77 | 6.3% |
| MOROCCO | $2.1M | 62 | 3.8% |
| VIETNAM, DEMOCRATIC REP. OF | $530.4K | 29 | 0.9% |
| MYANMAR | $412.9K | 20 | 0.7% |
| VIETNAM | $228.3K | 10 | 0.4% |
| OMAN | $222.3K | 5 | 0.4% |
Sun Pharmaceutical Industries Ltd exports Esomeprazole to 23 countries. The largest destination is BELGIUM accounting for 35.3% of Sun Pharmaceutical Industries Ltd's Esomeprazole shipments, followed by AUSTRALIA (21.7%) and BRAZIL (20.7%). These destinations reflect Sun Pharmaceutical Industries Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $18.8M | 632 |
| SUN PHARMA ANZ PTY LTD. | AUSTRALIA | $6.3M | 219 |
| EUROFARMA LABORAT?RIOS S/A | BRAZIL | $2.8M | 61 |
| M/S. SUN PHARMA ANZ PTY LTD | AUSTRALIA | $2.3M | 63 |
| SUN PHARMA ANZ PTY LTD | AUSTRALIA | $2.2M | 59 |
| SUN PHARMA CANADA INC | CANADA | $1.8M | 47 |
| RANBAXY FARMACEUTICA LTDA : | BRAZIL | $1.5M | 36 |
| SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $1.1M | 40 |
| RANBAXY PHARMACEUTICALS PTY LTD., | SOUTH AFRICA | $1.1M | 23 |
| ACH? LABORAT?RIOS FARMAC?UTICOS S.A | BRAZIL | $997.4K | 22 |
Sun Pharmaceutical Industries Ltd supplies Esomeprazole to 123 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by SUN PHARMA ANZ PTY LTD. (AUSTRALIA) and EUROFARMA LABORAT?RIOS S/A (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $207.7M worth of Esomeprazole through 9,532 shipments from 643 suppliers to 147 countries, serving 1,634 buyers globally. Sun Pharmaceutical Industries Ltd contributes $3.1M to this total, accounting for 0.7% of India's Esomeprazole exports. Sun Pharmaceutical Industries Ltd ships Esomeprazole to 23 countries through 123 buyers.
Sun Pharmaceutical Industries Ltd's average Esomeprazole shipment value is $50.0K per consignment, based on 63 shipments totaling $3.1M. The largest destination is BELGIUM (35.3% of Sun Pharmaceutical Industries Ltd's Esomeprazole exports).
Sun Pharmaceutical Industries Ltd ranks #13 among 643 Indian Esomeprazole exporters with a 0.7% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($82.5M), CIPLA LIMITED ($30.6M), MICRO LABS LIMITED ($20.4M). Sun Pharmaceutical Industries Ltd processed 63 shipments to 8 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT | $11.3M | 307 |
| ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (APO-ESOMEPRAZOLE TAB 20MG(CFB) AUST) EACH GASTRORESISTANT TABLET | $862.2K | 26 |
| ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (APO-ESOMEPRAZOLE TAB 20MG(CFB) AUST) EACH GASTRORESISTANT TABLETPCS | $639.7K | 25 |
| ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20MG ( ESOMEPRAZOLE TAB GR 20MG) EACH GASTRORESISTANT TABLET CONTAINS: | $604.5K | 19 |
| NEXIPRAZ IV 40MG/VIAL (ESOMEPRAZOLE SODI | $600.0K | 12 |
| ESOMEPRA MAG TAB 40MG CONTAINS ESOMEPRAZOLE MAGNESIUM TAB. 40 MG PACK : 4X7S | $428.8K | 9 |
| ESOMEPRAZOL MAG TAB 20MG ( ESOMEPRAZOLE)PACK : 4X7S | $427.9K | 11 |
| ESOMEPRAZOLE MAGNESIUM GASTRO-RESISTANTCAPSULES 40MG ( ESOMEPRAZOL BASICS CAP 40MG ) EACH GASTRORESISTANT CAPSULE CONTA | $370.7K | 13 |
| ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 40 MG (APO-ESOMEPRAZOLE TAB40MG(CFB) AUST) EACH GASTRORESISTANT TABLET | $339.8K | 10 |
| ESOMEPRAZOLE MAGNESIUM GASTRO-RESISTANTCAPSULES 20MG ( ESOMEPRAZOL BASICS CAP 20MG ) EACH GASTRORESISTANT CAPSULE CONTA | $339.6K | 16 |
Sun Pharmaceutical Industries Ltd exports 774 distinct Esomeprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT with 307 shipments worth $11.3M.
What Sun Pharmaceutical Industries Ltd must comply with to export Esomeprazole to its top destination countries
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | ANNORA PHARMA PRIVATE LIMITED | $5.7M | 155 | 1 | $36.6K |
| 10 | JUBILANT GENERICS LIMITED | $5.2M | 179 | 10 | $28.9K |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LTD ★ | $3.1M | 63 | 8 | $50.0K |
| 14 | PELL TECH HEALTH CARE PRIVATE LIMITED | $3.0M | 72 | 5 | $42.3K |
| 11 | DR REDDYS LABORATORIES LIMITED | $2.9M | 58 | 2 | $50.0K |
Sun Pharmaceutical Industries Ltd ranks #13 among 643 Indian Esomeprazole exporters. Average shipment value of $50.0K compared to the market average of $323.1K. The closest competitors by value are ANNORA PHARMA PRIVATE LIMITED and JUBILANT GENERICS LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 829 | 8.7% |
| SAHAR AIR | 824 | 8.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 7.4% |
| DELHI AIR CARGO ACC (INDEL4) | 630 | 6.6% |
| DELHI AIR | 522 | 5.5% |
| JNPT/ NHAVA SHEVA SEA | 393 | 4.1% |
| JNPT | 361 | 3.8% |
| CMA CGM LOGISTICS PARK ICD | 305 | 3.2% |
Latest developments and market context
Detailed market intelligence for Esomeprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 147+ countries, 1,634+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sun Pharmaceutical Industries Ltd's Esomeprazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sun Pharmaceutical Industries Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Sun Pharmaceutical Industries Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Esomeprazole. For current shipment-level data, contact TransData Nexus.